These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953 [TBL] [Abstract][Full Text] [Related]
4. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343 [TBL] [Abstract][Full Text] [Related]
5. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related]
6. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382 [TBL] [Abstract][Full Text] [Related]
7. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495 [TBL] [Abstract][Full Text] [Related]
8. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial. Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198 [TBL] [Abstract][Full Text] [Related]
9. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. Nair P; Pizzichini MM; Kjarsgaard M; Inman MD; Efthimiadis A; Pizzichini E; Hargreave FE; O'Byrne PM N Engl J Med; 2009 Mar; 360(10):985-93. PubMed ID: 19264687 [TBL] [Abstract][Full Text] [Related]
10. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity. Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396 [TBL] [Abstract][Full Text] [Related]
13. The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma. Abadoglu O; Mungan D; Aksu O; Erekul S; Misirligil Z Allergol Immunopathol (Madr); 2005; 33(2):105-11. PubMed ID: 15808118 [TBL] [Abstract][Full Text] [Related]
14. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656 [TBL] [Abstract][Full Text] [Related]
15. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Daikh BE; Ryan CK; Schwartz RH Ann Allergy Asthma Immunol; 2003 Jan; 90(1):23-7. PubMed ID: 12546333 [TBL] [Abstract][Full Text] [Related]
16. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of montelukast in the treatment of cough variant asthma. Spector SL; Tan RA Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381 [TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of intravenous montelukast in acute asthma. Camargo CA; Smithline HA; Malice MP; Green SA; Reiss TF Am J Respir Crit Care Med; 2003 Feb; 167(4):528-33. PubMed ID: 12456380 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. Belda J; Margarit G; Martínez C; Bellido-Casado J; Casan P; Torrejón M; Brufal M; Rodríguez-Jerez F; Sanchis J Eur Respir J; 2007 Dec; 30(6):1143-9. PubMed ID: 17690122 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of fluticasone and montelukast on allergen-induced asthma. Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]